25Oct
22Oct
Drug Resistant Diseases
Don Straus explains how his firm First Light Biosciences is pioneering a way of better diagnosing infections in order to avoid overprescribing antibiotics. Listen now >>
19Oct
Corbus Pharma (CRBP) Receives EC Orphan Designation for Resunab as CF Treatment
Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) announced that the European Commission has granted Orphan Designation in the European Union for the Company's novel synthetic oral endocannabinoid-mimetic drug, Resunab, for the treatment of cystic fibrosis ("CF"). Read more >>
16Oct
The New Space Race: XCOR Lynx
See more about XCOR and its Lynx, an airplane-like rocketship that could one day make four flights a day, five days a week. Read more >>
15Oct
Meet XCOR, One Of The Little Guys In The Commercial Spaceflight Race
XCOR’s aim is for daily space flights. Watch this interview with XCOR founder Jeff Greason. Watch now >>
14Oct
Corbus Pharmaceuticals Announces Completion of Phase 2 Study of Resunab for Systemic Sclerosis
Corbus Pharmaceuticals Holdings, Inc. (CRBP), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that it has completed the Phase 2 study evaluating Resunab for the treatment of diffuse cutaneous systemic sclerosis ("systemic sclerosis"). Corbus expects to report topline data from this study in the fourth quarter of 2016. Read more >>
14Oct
With a high-speed camera that live-streams video, goggles give visually impaired users a new look at life
Alex Curtis’ grandchildren think the thick goggles make him look like a spaceman. With the dark lenses and the cord snaking down to a set of dials and controls, the device does look futuristic. But what people see when Curtis wears the eSight device doesn’t matter to him. Read more >>
14Oct
Blind WI mom tries on glasses to see, hopes to read to kids
A mother in Wisconsin hopes to one day be able to read to her children. Right now, it's difficult for her to do that since she is legally blind. Stephanie Geiger from Grand Chute was diagnosed with Cone Rod Dystrophy at the age of 24. It's difficult for her to see depth perception, certain colors, and details. Recently, she got to try out eSight eyewear which uses high optics and resolution procession to improve eye sight. Read...
13Oct
RetroSense to be honored at TechTown awards program for $60 million sale
Sean Ainsworth, the CEO of Ann Arbor-based RetroSense Therapeutics LLC, will be honored as entrepreneur of the year Thursday night at TechTown Detroit's annual Toast of the Town awards program. Read more >>
12Oct